ORP-2 Activators
ORP-2 activators include a variety of compounds, primarily involved in modulating lipid metabolism and signaling pathways. These compounds can indirectly affect the activity of ORP-2 through several distinct mechanisms. For example, Liver X receptor (LXR) agonists, such as GW3965 and T0901317, can enhance the expression of proteins associated with lipid metabolism, thereby potentially increasing the functional demand for ORP-2 in lipid transport processes.
PPAR agonists like rosiglitazone and pioglitazone, by modulating lipid droplet dynamics, as well as fenofibrate, by stimulating fatty acid oxidation, can create a cellular environment that necessitates the lipid transfer role of ORP-2. Furthermore, PI3K inhibitors like LY294002 can impact phosphoinositide levels, which are important for membrane dynamics and may influence the functional context in which ORP-2 operates. Lastly, chemical chaperones such as 4-Phenylbutyrate can aid in proper folding and stability of lipid transfer proteins including ORP-2, ensuring their optimal activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
GW 3965 hydrochloride | 405911-17-3 | sc-224011 sc-224011A sc-224011B | 5 mg 25 mg 1 g | $140.00 $483.00 $3121.00 | ||
Liver X receptor (LXR) agonist, can induce expression of genes involved in lipid metabolism, potentially increasing ORP-2 activity. | ||||||
T 0901317 | 293754-55-9 | sc-202824 sc-202824A | 10 mg 50 mg | $89.00 $224.00 | 5 | |
Synthetic LXR agonist, can promote transcription of lipid metabolism-related proteins, potentially enhancing the role of ORP-2. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $120.00 $326.00 $634.00 $947.00 $1259.00 | 38 | |
PPARγ agonist, can modulate lipid storage and metabolism, potentially affecting the lipid transfer process involving ORP-2. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $55.00 $125.00 | 13 | |
Another PPARγ agonist, can influence lipid droplet formation and metabolism, which may indirectly affect ORP-2 function. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $41.00 | 9 | |
PPARα agonist, stimulates fatty acid oxidation, possibly increasing demand for lipid transfer activities where ORP-2 is involved. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor, can affect the phosphoinositide levels and indirectly modulate lipid signaling pathways associated with ORP-2. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $33.00 | ||
PPAR agonist, can influence lipid homeostasis, potentially enhancing the transfer activity of ORP-2. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Chemical chaperone, can enhance protein folding and stability, possibly improving the functional expression of ORP-2. | ||||||